Vor Biopharma OverviewVor Biopharma Other Income Expense Net
Other Income/Expense Net for VOR.
Quarterly Other Income/Expense
-$184.43M
↓ 23009.94% YoY
As of Mar 31, 2026
Annual Other Income/Expense (TTM)
-$509.57M
↓ 14437.9% YoY
Trailing 12 months ending Mar 31, 2026